Acquisitions - Bluegrass Vascular Technologies (Details) - USD ($) $ in Thousands |
May 04, 2023 |
May 03, 2023 |
---|---|---|
Bluegrass Vascular Technologies, Inc | ||
Business Acquisition [Line Items] | ||
Total purchase price | $ 32,700 | |
Bluegrass Vascular Technologies, Inc | Weighted Average | ||
Business Acquisition [Line Items] | ||
Amortization period | 14 years 10 months 24 days | |
Bluegrass Vascular Technologies, Inc | Developed technology | ||
Business Acquisition [Line Items] | ||
Amortization period | 15 years | |
Bluegrass Vascular Technologies, Inc | Trademarks | ||
Business Acquisition [Line Items] | ||
Amortization period | 13 years | |
Bluegrass Vascular Technologies, Inc | ||
Business Acquisition [Line Items] | ||
Ownership percentage | 19.50% | |
Investment of common shares | 1,251,878 | |
Equity method investment | $ 245 |
X | ||||||||||
- Definition Number of shares owned as equity method investment. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|